Get the Stockscreener App
0.2564
2.73%
-0.0072
After Hours:
.26
0.0036
+1.40%
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.2564, with a volume of 2.31M.
It is down -2.73% in the last 24 hours and down -21.11% over the past month.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.2636
Open:
$0.264
24h Volume:
2.31M
Relative Volume:
0.47
Market Cap:
$29.96M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.3945
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
+0.55%
1M Performance:
-21.11%
6M Performance:
-44.26%
1Y Performance:
-86.29%
1-Day Range:
$0.2549
$0.2679
1-Week Range:
$0.2549
$0.307
52-Week Range:
$0.25
$1.90
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Name
Reviva Pharmaceuticals Holdings Inc
Sector
Industry
Phone
(408) 501-8881
Address
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.2564 | 30.80M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-29-25 | Initiated | Chardan Capital Markets | Buy |
| Sep-20-23 | Initiated | ROTH MKM | Buy |
| Jun-08-23 | Initiated | The Benchmark Company | Speculative Buy |
| Jan-24-22 | Initiated | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News
Price Action: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentGlobal Markets & Weekly High Return Stock Forecasts - baoquankhu1.vn
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs in weak economy2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-02 10:12:16 - baoquankhu1.vn
Rate Hike: What is the next catalyst for TLYSMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Aug Gainers: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflationBond Market & Verified Momentum Stock Ideas - baoquankhu1.vn
Retail Trends: What’s the fair value of OSIS stockMarket Sentiment Review & AI Driven Price Predictions - baoquankhu1.vn
Aug Selloffs: Can Reviva Pharmaceuticals Holdings Inc deliver alphaWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Guidance Update: Is TLRY a good stock for dollar cost averagingTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn
Published on: 2026-01-30 02:52:59 - baoquankhu1.vn
Breakout Watch: Does Franklin Wireless Corp have declining or rising EPSEarnings Overview Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Market Leaders: Will DXPRC outperform tech stocks2025 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC) - The Globe and Mail
Gainers Report: What analysts say about Reviva Pharmaceuticals Holdings Inc stockInsider Buying & Low Volatility Stock Suggestions - baoquankhu1.vn
Chart Watch: Does BlackRock Science and Technology Trust have declining or rising EPSJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Volume: Is ProShares Trust ProShares UltraShort Real Estate exposed to political risk2025 AllTime Highs & Long-Term Capital Growth Ideas - baoquankhu1.vn
Reviva Pharmaceuticals Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Moving Averages: Can IGNEP be the next market leaderWeekly Trend Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug EndMonth: What analysts say about Reviva Pharmaceuticals Holdings Inc stockEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
Support Test: What makes Reviva Pharmaceuticals Holdings Inc stock attractive today2025 Market WrapUp & AI Driven Stock Movement Reports - baoquankhu1.vn
Trade Report: Is now the right time to enter Reviva Pharmaceuticals Holdings IncEarnings Recap Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
Technical Analysis: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant withstand a market correction2025 Dividend Review & Precise Swing Trade Alerts - baoquankhu1.vn
Market Outlook: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant stock showing strong momentumJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn
RVPH: Brilaroxazine delivers strong efficacy and safety in schizophrenia, with NDA submission targeted for 2027 - TradingView
Sentiment Watch: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflationEarnings Growth Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Sectors Review: Will Reviva Pharmaceuticals Holdings Inc benefit from green energy policiesJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug Levels: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant stock a top pick in earnings season2025 Fundamental Recap & Low Drawdown Momentum Ideas - Bộ Nội Vụ
Breakouts Watch: How Reviva Pharmaceuticals Holdings Inc stock reacts to Fed rate cutsWeekly Stock Analysis & Community Consensus Trade Alerts - Bộ Nội Vụ
Profit Recap: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant withstand a market correctionAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far - Finviz
Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026 - Yahoo Finance
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock deliver sustainable ROEQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Weekly Recap & High Conviction Trade Alerts - Улправда
Aug Opening: How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
symbol__ Stock Quote Price and Forecast - CNN
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoptionRate Cut & Entry and Exit Point Strategies - Улправда
Is Reviva Pharmaceuticals Holdings Inc. stock trading near support levels2025 Market Outlook & High Yield Equity Trading Tips - Улправда
How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
Will Tonix Pharmaceuticals Holding Corp. stock see insider buyingTrade Volume Report & Smart Allocation Stock Tips - Улправда
Reviva Pharmaceuticals Holdings, Inc. Announces Publication on Clinical Vocal Biomarker Data from the Recover Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - marketscreener.com
Aug PreEarnings: How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoption2025 Macro Impact & Weekly Chart Analysis and Trade Guides - ulpravda.ru
Will Reviva Pharmaceuticals Holdings Inc. stock maintain dividend yield2025 Retail Activity & Daily Profit Maximizing Trade Tips - ulpravda.ru
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - The Manila Times
Reviva Announces Publication on Clinical Vocal Biomarker - GlobeNewswire
Study links speech delays to schizophrenia symptoms, may cut trial sizes - Stock Titan
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue dividend increases - Улправда
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue upward trendBlue Chip Stock Analysis & Free Long-Term Investment Planning - Улправда
Worth Investment Trading Company Limited Shows Risk Reward Favoring Upside - Early Times
Reviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Chardan Capital - The Globe and Mail
Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating - Investing.com Canada
Volatility Watch: Will Reviva Pharmaceuticals Holdings Inc Equity Warrant stock attract ESG investorsJuly 2025 Chart Watch & Verified Stock Trade Ideas - Bộ Nội Vụ
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):